160 related articles for article (PubMed ID: 36971044)
1. Development and external validation of nomograms for predicting individual survival in patients with ovarian clear cell carcinoma.
Liu X; Lu H; Zhou Y; Long X; Li Q; Zhuang G; Yin X; Di W
Cancer Med; 2023 May; 12(10):11385-11395. PubMed ID: 36971044
[TBL] [Abstract][Full Text] [Related]
2. Development and validation of Nomograms for predicting overall survival and Cancer-specific survival in patients with ovarian clear cell carcinoma.
Chen Q; Wang S; Lang JH
J Ovarian Res; 2020 Oct; 13(1):123. PubMed ID: 33069259
[TBL] [Abstract][Full Text] [Related]
3. Prognostic nomogram that predicts progression-free survival and overall survival of patients with ovarian clear cell carcinoma.
Li J; Cao D
Front Oncol; 2022; 12():956380. PubMed ID: 36387090
[TBL] [Abstract][Full Text] [Related]
4. Construction and validation of log odds of positive lymph nodes (LODDS)-based nomograms for predicting overall survival and cancer-specific survival in ovarian clear cell carcinoma patients.
Liu Z; Jing C; Hooblal YM; Yang H; Chen Z; Kong F
Front Oncol; 2024; 14():1370272. PubMed ID: 38577328
[TBL] [Abstract][Full Text] [Related]
5. Developing and validating a prognostic nomogram for ovarian clear cell carcinoma patients: A retrospective comparison of lymph node staging schemes with competing risk analysis.
Li Y; Xiu L; Ma M; Seery S; Lou X; Li K; Wu Y; Liang S; Wu Y; Cui W
Front Oncol; 2022; 12():940601. PubMed ID: 36439411
[TBL] [Abstract][Full Text] [Related]
6. Nomograms predicting the overall survival and cancer-specific survival of patients with stage IIIC1 cervical cancer.
Feng Y; Wang Y; Xie Y; Wu S; Li Y; Li M
BMC Cancer; 2021 Apr; 21(1):450. PubMed ID: 33892663
[TBL] [Abstract][Full Text] [Related]
7. Nomograms for Predicting Overall Survival and Cancer-Specific Survival of Young Patients with Epithelial Ovarian Cancer: Analysis Based on SEER Program.
Gao J; Wang S; Li F; Xu H; Li X; Yan L; Zhu L
Adv Ther; 2022 Jan; 39(1):257-285. PubMed ID: 34716558
[TBL] [Abstract][Full Text] [Related]
8. Nomograms based on SUVmax of
Li H; Shao G; Zhang Y; Chen X; Du C; Wang K; Gao Z
Cancer Imaging; 2021 Jan; 21(1):9. PubMed ID: 33419476
[TBL] [Abstract][Full Text] [Related]
9. Prognostic nomograms based on log odds of positive lymph nodes for patients with renal cell carcinoma: A retrospective cohort study.
Zhou W; Huang C; Yuan N
Int J Surg; 2018 Dec; 60():28-40. PubMed ID: 30389534
[TBL] [Abstract][Full Text] [Related]
10. Nomogram Based on microRNA Signature Contributes to Improve Survival Prediction of Clear Cell Renal Cell Carcinoma.
Zhao E; Bai X
Biomed Res Int; 2020; 2020():7434737. PubMed ID: 32280701
[TBL] [Abstract][Full Text] [Related]
11. Development and Validation of a Nomogram-Based Prognostic Evaluation Model for Sarcomatoid Hepatocellular Carcinoma.
Ge D; Luo Z; Mao R; Zhao H; Lv X; Zhao J; Zhou J; Huang Z; Zhang Y; Li Z; Bi X; Cai J
Adv Ther; 2020 Jul; 37(7):3185-3205. PubMed ID: 32436026
[TBL] [Abstract][Full Text] [Related]
12. Nomograms for predicting overall and cancer-specific survival of patients with chromophobe renal cell carcinoma after nephrectomy: a retrospective SEER-based study.
Zheng J; Li S; Zhao Y; Tao Z; Li L; Li Z; Li M; Chen X
BMJ Open; 2022 Sep; 12(9):e062129. PubMed ID: 36581979
[TBL] [Abstract][Full Text] [Related]
13. A nomogram for predicting overall survival in patients with low-grade endometrial stromal sarcoma: A population-based analysis.
Wu J; Zhang H; Li L; Hu M; Chen L; Xu B; Song Q
Cancer Commun (Lond); 2020 Jul; 40(7):301-312. PubMed ID: 32558385
[TBL] [Abstract][Full Text] [Related]
14. Construction and Validation of a Nomogram for Predicting Progression- Free Survival in Patients with Early-Stage Testicular Germ Cell Tumor.
Chen JG; Wang JQ; Peng TW; Chen ZS; Zhao SC
Recent Pat Anticancer Drug Discov; 2021; 16(1):44-53. PubMed ID: 33573563
[TBL] [Abstract][Full Text] [Related]
15. Prognostic nomogram based on the lymph node metastasis indicators for patients with bladder cancer: A SEER population-based study and external validation.
Li S; Wang Y; Hu X
Cancer Med; 2023 Mar; 12(6):6853-6866. PubMed ID: 36479835
[TBL] [Abstract][Full Text] [Related]
16. Construction and validation of prognostic nomograms for elderly patients with metastatic non-small cell lung cancer.
Sun H; Liu M; Yang X; Ren Y; Dai H; Wang C
Clin Respir J; 2022 May; 16(5):380-393. PubMed ID: 35514033
[TBL] [Abstract][Full Text] [Related]
17. Predicting 5-Year Progression and Survival Outcomes for Early Stage Non-small Cell Lung Cancer Treated with Stereotactic Ablative Radiation Therapy: Development and Validation of Robust Prognostic Nomograms.
Kang J; Ning MS; Feng H; Li H; Bahig H; Brooks ED; Welsh JW; Ye R; Miao H; Chang JY
Int J Radiat Oncol Biol Phys; 2020 Jan; 106(1):90-99. PubMed ID: 31586665
[TBL] [Abstract][Full Text] [Related]
18. A nomogram model based on the number of examined lymph nodes-related signature to predict prognosis and guide clinical therapy in gastric cancer.
Li H; Lin D; Yu Z; Li H; Zhao S; Hainisayimu T; Liu L; Wang K
Front Immunol; 2022; 13():947802. PubMed ID: 36405735
[TBL] [Abstract][Full Text] [Related]
19. Nomograms for predicting overall survival and cancer-specific survival in elderly patients with epithelial ovarian cancer.
Cheng H; Xu JH; Kang XH; Wu CC; Tang XN; Chen ML; Lian ZS; Li N; Xu XL
J Ovarian Res; 2023 Apr; 16(1):75. PubMed ID: 37059991
[TBL] [Abstract][Full Text] [Related]
20. Nomograms for predicting long-term overall survival and cancer-specific survival in patients with primary urethral carcinoma: a population-based study.
Zi H; Gao L; Yu Z; Wang C; Ren X; Lyu J; Li X
Int Urol Nephrol; 2020 Feb; 52(2):287-300. PubMed ID: 31612421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
